Renaissance Technologies’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $248K | Buy |
27,300
+14,800
| +118% | +$134K | ﹤0.01% | 3100 |
|
2025
Q1 | $119K | Sell |
12,500
-10,200
| -45% | -$97.3K | ﹤0.01% | 3166 |
|
2024
Q4 | $255K | Sell |
22,700
-9,800
| -30% | -$110K | ﹤0.01% | 3089 |
|
2024
Q3 | $467K | Sell |
32,500
-4,400
| -12% | -$63.2K | ﹤0.01% | 2823 |
|
2024
Q2 | $637K | Sell |
36,900
-600
| -2% | -$10.4K | ﹤0.01% | 2580 |
|
2024
Q1 | $748K | Buy |
37,500
+900
| +2% | +$18K | ﹤0.01% | 2665 |
|
2023
Q4 | $385K | Sell |
36,600
-17,698
| -33% | -$186K | ﹤0.01% | 2882 |
|
2023
Q3 | $480K | Sell |
54,298
-24,902
| -31% | -$220K | ﹤0.01% | 2719 |
|
2023
Q2 | $764K | Buy |
79,200
+28,400
| +56% | +$274K | ﹤0.01% | 2636 |
|
2023
Q1 | $701K | Buy |
50,800
+17,500
| +53% | +$241K | ﹤0.01% | 2694 |
|
2022
Q4 | $506K | Sell |
33,300
-23,401
| -41% | -$356K | ﹤0.01% | 2942 |
|
2022
Q3 | $516K | Sell |
56,701
-48,458
| -46% | -$441K | ﹤0.01% | 2917 |
|
2022
Q2 | $891K | Buy |
+105,159
| New | +$891K | ﹤0.01% | 2788 |
|
2022
Q1 | – | Sell |
-30,000
| Closed | -$730K | – | 4206 |
|
2021
Q4 | $730K | Buy |
+30,000
| New | +$730K | ﹤0.01% | 2883 |
|